May 03, 2023 08:00 AM

Furen Group Pharmaceutical Co.,Ltd. Posted 2.8 Billion Yuan Net Loss in 2022

00:00

00:00/00:00

Listen to this article 1x

Furen Group Pharmaceutical Co.,Ltd. (辅仁药业集团制药股份有限公司) (600781.SH) reported a net loss of 2.8 billion yuan in 2022, narrowing 12.4% year-on-year.

Meanwhile, the company posted 1.5 billion yuan in revenue, down 2.9% year-on-year.

At the end of the reporting period, it had 6.3 billion yuan in total assets and 8.3 billion yuan in total liabilities, with a liability-to-asset ratio of 133.3%.

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Save an extra $50. Introductory offer for new readers. Subscribe now.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Huaiyang Cuisine Takes Center Stage at Trump Banquet

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

China Business Uncovered Podcast: Inside Vanke and China’s Property Reckoning

00:00

00:00/00:00

MOST POPULAR

1: Charts of the Day: Huawei Partners’ EV Sales Lead China Upstarts

2: In Depth: As China’s Hidden Local Debts Shrink, a New Challenge Emerges

3: China Taps Industry Veteran Ding Xiangqun to Lead Top Financial Regulator

4: EU Fines Temu 200 Million Euros for Letting in Unsafe Products

5: Analysis: Why China’s Carmakers Fear Falling Behind Without Huawei